Stock ESPR ESPERION THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Comparison Chart Esperion Therapeutics, Inc.

Equities

ESPR

US29664W1053

Market Closed - Nasdaq
Other stock markets
 01:29:48 05/06/2024 am IST 		5-day change 1st Jan Change
2.25 USD +0.45% Intraday chart for Esperion Therapeutics, Inc. +7.14% -24.75%
22/05 Daiichi Sankyo Europe GmbH and Esperion Therapeutics, Inc. Jointly Announce That European Commission Has Approved the Label Update of Both NILEMDO® (bempedoic acid) and NUSTENDI® (bempedoic acid / ezetimibe fixed-dose combination), as Treatments for Hypercholesterolemia and to Reduce the Risk of Adverse Cardiovascular Events CI
20/05 Esperion Therapeutics Says Primary Endpoint Achieved in Hypercholesterolemia Treatment Phase 3 Trial; Shares Rise MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ESPERION THERAPEUTICS, INC.
Other Pharmaceuticals
+0.45%+7.14%-24.75%+65.44%-95.51% 426M
Neutral
Neutral
Bullish

Technical Rankings Surperformance

  1. Stock Market
  2. Equities
  3. ESPR Stock
  4. Charts Esperion Therapeutics, Inc.
  5. Comparison Chart